Your browser doesn't support javascript.
loading
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS).
Morschhauser, Franck; Flinn, Ian W; Advani, Ranjana; Sehn, Laurie H; Diefenbach, Catherine; Kolibaba, Kathryn; Press, Oliver W; Salles, Gilles; Tilly, Hervé; Chen, Andy I; Assouline, Sarit; Cheson, Bruce D; Dreyling, Martin; Hagenbeek, Anton; Zinzani, Pier Luigi; Jones, Surai; Cheng, Ji; Lu, Dan; Penuel, Elicia; Hirata, Jamie; Wenger, Michael; Chu, Yu-Waye; Sharman, Jeff.
Afiliação
  • Morschhauser F; Université Lille, Centre Hospitalier Régional Universitaire de Lille, EA 7365, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. Electronic address: franck.morschhauser@chru-lille.fr.
  • Flinn IW; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA.
  • Advani R; Stanford Cancer Center, Stanford, CA, USA.
  • Sehn LH; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada.
  • Diefenbach C; New York University Medical Center, New York, NY, USA.
  • Kolibaba K; US Oncology and Compass Oncology, Vancouver, WA, USA.
  • Press OW; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Salles G; Hospices Civils de Lyon, Pierre Bénite, France.
  • Tilly H; Centre Henri Becquerel, Rouen, France.
  • Chen AI; Oregon Health and Science University, Portland, OR, USA.
  • Assouline S; Jewish General Hospital, Montreal, Canada.
  • Cheson BD; Georgetown University Hospital, Washington, DC, USA.
  • Dreyling M; Department of Medicine 3, University Hospital, Ludwig Maximilian University Munich, Munich, Germany.
  • Hagenbeek A; Academic Medical Center, Amsterdam, Netherlands.
  • Zinzani PL; Institute of Hematology, University of Bologna, Bologna, Italy.
  • Jones S; Genentech, San Francisco, CA, USA.
  • Cheng J; Genentech, San Francisco, CA, USA.
  • Lu D; Genentech, San Francisco, CA, USA.
  • Penuel E; Genentech, San Francisco, CA, USA.
  • Hirata J; Genentech, San Francisco, CA, USA.
  • Wenger M; Genentech, San Francisco, CA, USA.
  • Chu YW; Genentech, San Francisco, CA, USA.
  • Sharman J; US Oncology and Willamette Valley Cancer Institute, Springfield, OR, USA.
Lancet Haematol ; 6(5): e254-e265, 2019 May.
Article em En | MEDLINE | ID: mdl-30935953
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article